We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+4.63%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$921M
AUM Growth
-$85.5M
Cap. Flow
-$110M
Cap. Flow %
-11.98%
Top 10 Hldgs %
14.09%
Holding
5,143
New
1,384
Increased
1,284
Reduced
1,171
Closed
1,233

Sector Composition

Rank Sector Weight
1 Financials 13.75%
2 Technology 8.29%
3 Industrials 7.33%
4 Healthcare 6.94%
5 Consumer Discretionary 6.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SSP icon
2151
E.W. Scripps
SSP
$304M
$20K ﹤0.01%
1,047
-272
-21% -$4.41K
SSTK icon
2152
Shutterstock
SSTK
$219M
$20K ﹤0.01%
+421
New +$22.5K
ST icon
2153
Sensata Technologies
ST
$6.79B
$20K ﹤0.01%
510
-357
-41% -$13.6K
TBBK icon
2154
The Bancorp
TBBK
$2.84B
$20K ﹤0.01%
+2,613
New +$18.7K
TDS icon
2155
Telephone and Data Systems
TDS
$3.75B
$20K ﹤0.01%
680
-1,547
-69% -$42.2K
TZOO icon
2156
Travelzoo
TZOO
$75.4M
$20K ﹤0.01%
2,119
+1,886
+809% +$20.9K
UI icon
2157
Ubiquiti
UI
$34.3B
$20K ﹤0.01%
+343
New +$18.7K
WASH icon
2158
Washington Trust Bancorp
WASH
$741M
$20K ﹤0.01%
356
-103
-22% -$5.05K
CUTR
2159
DELISTED
Cutera, Inc.
CUTR
$20K ﹤0.01%
+1,135
New +$17K
CDMO
2160
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$20K ﹤0.01%
9,223
+8,628
+1,450% +$20.2K
PRFT
2161
DELISTED
Perficient Inc
PRFT
$20K ﹤0.01%
+1,113
New +$20.3K
IMGN
2162
DELISTED
Immunogen Inc
IMGN
$20K ﹤0.01%
+9,632
New +$19.3K
CCF
2163
DELISTED
Chase Corporation
CCF
$20K ﹤0.01%
+234
New +$17.8K
MIC
2164
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
$20K ﹤0.01%
240
+156
+186% +$12.8K
TSC
2165
DELISTED
TriState Capital Holdings, Inc.
TSC
$20K ﹤0.01%
+923
New +$17.5K
CSS
2166
DELISTED
CSS Industries, Inc.
CSS
$20K ﹤0.01%
737
+637
+637% +$16.8K
GNMX
2167
DELISTED
Aevi Genomic Medicine Inc
GNMX
$20K ﹤0.01%
+3,870
New +$20.4K
BPL
2168
DELISTED
Buckeye Partners, L.P.
BPL
$20K ﹤0.01%
+299
New +$19.7K
KEYW
2169
DELISTED
The KEYW Holding Corporation
KEYW
$20K ﹤0.01%
+1,639
New +$19.3K
TVPT
2170
DELISTED
Travelport Worldwide Limited
TVPT
$20K ﹤0.01%
1,451
-2,531
-64% -$35.2K
AFSI
2171
DELISTED
AmTrust Financial Services, Inc.
AFSI
$20K ﹤0.01%
745
+728
+4,282% +$19.4K
PERY
2172
DELISTED
Perry Ellis International Inc
PERY
$20K ﹤0.01%
+803
New +$18K
RSO
2173
DELISTED
Resource Capital Corp.
RSO
$20K ﹤0.01%
2,480
+888
+56% +$9.21K
ACTA
2174
DELISTED
Actua Corp
ACTA
$20K ﹤0.01%
1,374
+1,063
+342% +$14K
DFT
2175
DELISTED
DuPont Fabros Technology Inc.
DFT
$20K ﹤0.01%
460
+23
+5% +$947

Similar funds

Tower Research Capital (TRC)'s Q4 2016 Portfolio in Review

As of Q4 2016, Tower Research Capital (TRC) held 5,143 positions worth $921M, down 8.5% from $1.01B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Tower Research Capital (TRC) withdrew a net $110M in Q4 2016, closing 1,233 positions and reducing 1,171 holdings. Its most notable exit was Vanguard Real Estate ETF, an estimated $18.2M position sold in full.

By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 3.3% a quarter earlier, followed by Technology and Industrials.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Biotechnology ETF worth $9.93M.

  • Tower Research Capital (TRC)'s largest Q4 2016 buy was iShares Biotechnology ETF: 112,296 shares worth $9.93M.
  • Tower Research Capital (TRC) added most to Microsoft in Q4 2016, an estimated $11.2M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $265M.
  • Tower Research Capital (TRC) fully exited Vanguard Real Estate ETF in Q4 2016, selling an estimated $18.2M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 14% of its $921M portfolio in Q4 2016.
  • Tower Research Capital (TRC) opened 1,384 new positions and closed 1,233 in Q4 2016.
  • Tower Research Capital (TRC)'s portfolio value fell 8.5% quarter-over-quarter to $921M.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2016, filed 3 Feb 2017.